The instrument is based off of triboluminescence and works by measuring light emitted when a pharmaceutical powder is crushed

IONTAS will use its proprietary antibody discovery platforms to deliver antibodies against biological targets selected by aTen

The authors of a new report illustrate how a magnetic nanoparticle assembly approach is used to increase throughput dramatically while reducing costs

The team determined the first crystal structure for a neuropeptide Y receptor, deciphering the thousands of carbon, oxygen, nitrogen, and other atoms involved with it and how they bind to one another

In preclinical tests, researchers from UNC-Chapel Hill and Oregon Health and Sciences University showed how a new compound can immobilize sperm temporarily without side effects

Targeting an opioid receptor calms itch

Substudy analysis shows adding aspirin erases some of the safety benefits of celecoxib seen in 2016 PRECISION trial

Unlike conventional methods of HIV prevention, such as condoms or anti-HIV drugs, the recently-created implant takes advantage of some people’s natural immunity to the virus

Fast and repeated assessments of tumor sensitivity to available drugs can improve clinical outcomes by staying ahead of a cancer's ability to resist certain therapies

A novel personalized vaccine made using patients’ tumor tissue and immune cells stimulates potent therapeutic immune responses, extending overall survival of patients with recurrent ovarian cancer

A multi-institutional project to understand one of the major targets of human drug design has produced new insights into how structural communication works in a cell component called a G protein-coupled receptor

The researchers studied ferric citrate and ferric EDTA, which have both previously been shown to worsen tumor formation in mice with colon cancer